Description IGF-1 LR3 1mg Research Peptide Laboratory Formulation (1mg Total) The IGF-1 LR3 1mg research formulation contains 1mg of insulin-like growth factor-1 LR3 (IGF-1 LR3), supplied in a sealed vial format for laboratory and analytical applications
At the start of treatment, 1 ml (1 ampoule) of Vitamin B12-Depot-Injektopas 1500 g (equivalent to 1500 g hydroxocobalamin acetate) is administered twice a week for the first few weeks after diagnosis
It is compatible with the vast majority of research peptides that dissolve readily at neutral or mildly acidic pH including most GLP-1 analogues, amylin analogues, and other water-soluble peptide preparations supplied by Peptides Lab UK
In the UK, meat, dairy, and fortified products remain the main dietary sources
When the research question specifically isolates these two mechanisms, adding GHK-Cu introduces confounding from its gene-expression and anti-inflammatory effects